Pyxis Oncology Inc
Ownership
Ownership Structure
Who owns Pyxis Oncology Inc (PYXS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 45.8% of the shares are freely tradable; institutional investors hold 33.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| GordonMD Global Investments LP | 15.99 | 10,024,909 | +143.2 | 06/30/2026 |
| Pfizer Inc | 11.22 | 7,032,770 | +0.0 | 06/30/2026 |
| LAURION CAPITAL MANAGEMENT LP | 7.82 | 4,900,888 | -1.9 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.31 | 2,075,997 | +2.1 | 06/30/2026 |
| Atle Fund Management AB | 1.54 | 966,459 | +390.5 | 06/30/2026 |
| 683 Capital Management LLC | 1.43 | 896,263 | +0.5 | 03/31/2026 |
| BlackRock Inc | 1.38 | 867,934 | +10.0 | 06/30/2026 |
| Palo Alto Investors, LLC | 1.38 | 864,277 | -14.5 | 06/30/2026 |
| Marshall Wace Asset Management Ltd | 1.32 | 830,544 | +134.3 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 5.15 | 3,227,492 | +100.2 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| GordonMD Global Investments LP | 10% Owner | 15,541,909 | 26,421,245 $ | Oct 1, 2026 | indirect |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | GordonMD Global Investments LP | 10% Owner | Buy | 5,517,000 | – | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.